Celebrating Dr. John McLaughlin and Welcoming Dr. Jennifer Brooks

Dr. John McLaughlin is retiring as CanPath Executive Director and has been awarded Professor Emeritus status at the University of Toronto, while Dr. Jennifer Brooks will assume the role starting October 2, 2023. It has been a true pleasure for our Atlantic PATH team members to work with Dr. McLaughlin. He will be missed and Read more about Celebrating Dr. John McLaughlin and Welcoming Dr. Jennifer Brooks[…]

CanPath is Hiring: Research Operations Manager

Join the CanPath team as the new Research Operations Manager at the University of Toronto. Deadline: September 22, 2023. “CanPath is Canada’s largest population health cohort and a national platform for population-level health research. CanPath is studying the biology, behaviours and environments of Canadians to learn more about the causes of chronic disease and cancer Read more about CanPath is Hiring: Research Operations Manager[…]

CanPath Scientific Director presents at AGBT Meeting

Advances in Genome Biology and Technology (AGBT) is “considered the preeminent genome science and technology conference where top global researchers, leaders and innovators meet to announce new discoveries, cutting edge breakthroughs and to collaborate.” CanPath Scientific Director, Dr. Philip Awadalla attended the AGBT Precision Health meeting in San Diego, California from September 7-9, 2023. Dr. Read more about CanPath Scientific Director presents at AGBT Meeting[…]

CH&E Seminar Series – Dr. Kelvin Fong (Sept 2023)

We are looking forward to attend our colleague, Dr. Kelvin Fong’s presentation in the Dalhousie University Department of Community Health and Epidemiology‘s Seminar Series on September 13th at 12pm AST (11am EST). Dr. Fong’s presentation is entitled, “How does the Environment Contribute to Health in Atlantic Canada?”  Dr. Fong is an assistant professor at Dalhousie University Read more about CH&E Seminar Series – Dr. Kelvin Fong (Sept 2023)[…]

Melanoma Risk in Atlantic Canada

New work from Dr. Ivan Litvinov and Dr. François Lagacé  at McGill University includes Atlantic PATH participants and highlights why Atlantic Canadians are at higher risk for developing melanoma (skin cancer). The SunFit project conducted focus groups in 22 communities across Atlantic Canada.  Nova Scotia and Prince Edward Island have the highest rates of melanoma in the Read more about Melanoma Risk in Atlantic Canada[…]

New Publication – Depression, Anxiety and Risk of Cancer

We are pleased to share that the first results from the Psychosocial Factors and Cancer Incidence (PSY-CA) consortium have been published in Cancer. Led from the Netherlands by Dr. Lonneke van Tuijl and Dr. Joost Dekker, this study includes 18 cohorts with more than 300,000 participants including Atlantic PATH, the Ontario Health Study and CARTaGENE Read more about New Publication – Depression, Anxiety and Risk of Cancer[…]

COVID Global Mental Health Consortium Funded – 23 cohorts with 2.8 million participants

We’re excited to share that the collaborative project, “International Evaluation of Modifiable Social Determinants of Health on COVID-related Mental Health Outcomes” has been approved for funding from the National Institute of Mental Health (Mental Health Research Grant, award number 1RF1MH134638-01). Led by Dr. Jordan Smoller (Harvard University, Massachusetts General Hospital), Dr. Sarah Bauermeister (University of Oxford), and Read more about COVID Global Mental Health Consortium Funded – 23 cohorts with 2.8 million participants[…]

New Publication – Skin Cancer & Atlantic Canada

Atlantic PATH participants were invited to participate in the SunFit study led by Dr. Ivan Litvinov at McGill University. A new publication focuses on assessing skin cancer risk factors, sun safety behaviours and melanoma concern in Atlantic Canada. Melanoma skin cancer can largely be prevented through education, sun protection, screening, and public health campaigns. However, Read more about New Publication – Skin Cancer & Atlantic Canada[…]

Seroprevalence in Canada – New Data from CITF

“In order to tailor public health strategies to the current pandemic context, it is important to understand the prevalence of COVID-19 across Canada. Since the winter of 2021-22 with the onset of the Omicron wave, PCR testing for diagnosis of SARS-CoV-2 has failed to keep up with the rapid growth in infection across the population. Read more about Seroprevalence in Canada – New Data from CITF[…]

Pan-Canadian Cancer Data Strategy

The Canadian Cancer Society (CCS) and Canadian Partnership Against Cancer (CPAC) have launched the Pan-Canadian Cancer Data Strategy that will guide efforts to enhance the collection, integration and use of cancer data. “CPAC and CCS have worked with various partners, including provincial and territorial cancer agencies and programs, healthcare organizations, First Nations, Inuit and Métis partners, Read more about Pan-Canadian Cancer Data Strategy[…]